The drugmaker plans to launch Semaglutide in 87 countries next year, including those where patents are expiring and emerging ...

For Sarepta, the hits keep coming, with several downgrades in the past week after it was forced to temporarily take its ...

The "try and fail" language is flawed when weight loss is used as the primary measure of success with lifestyle interventions ...

Employers increasingly shift health benefit costs to workers in 2026, while prioritizing mental health and innovative affordability strategies.

On July 18, 2025, Director Jeffrey S. Flier disclosed the sale of 11,136 shares of Scholar Rock( SRRK -0.68%) in an open ...

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide ...

People who stop taking GLP-1 medications like Ozempic and Wegovy started to regain weight in a short amount of time, ...

Iran's state television says an Iranian navy helicopter has confronted a U.S. warship attempting to approach Iranian ...

GLP-1 medications, on average, can cost individuals $1,000 per month if their employers do not provide insurance coverage, Andrea Grande, a principal at Brown & Brown, said ...

Dealmaking in Europe’s life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength ...